Altimmune (ALT) Goodwill (2010 - 2017)

Altimmune (ALT) has 8 years of Goodwill data on file, last reported at $9.3 million in Q3 2017.

• Goodwill for Q3 2017 came in at $9.3 million, up 297.49% year-over-year; the trailing twelve-month figure through Sep 2017 was $9.3 million (up 297.49% YoY), and the FY2016 annual result was $18.8 million, down 16.61% from the prior year.
• Goodwill eased to $9.3 million in Q3 2017 per ALT's latest filing, from $35.4 million in the prior quarter.
• Over five years, Goodwill peaked at $35.4 million in Q2 2017 and troughed at $2.3 million in Q1 2013.
• A 5-year average of $6.6 million and a median of $2.3 million in 2013 frame the typical range for Goodwill.
• The sharpest annual moves came in 2016 and 2017: Goodwill slipped 16.61% in 2016, then soared 1407.33% in 2017.
• A 5-year view of Goodwill shows it stood at $2.3 million in 2013, then changed by 0.0% to $2.3 million in 2014, then soared by 857.85% to $22.5 million in 2015, then retreated by 16.61% to $18.8 million in 2016, then sank by 50.24% to $9.3 million in 2017.
• Business Quant data shows ALT's Goodwill at $9.3 million in Q3 2017, $35.4 million in Q2 2017, and $2.3 million in Q1 2017.